Transdermal Drug Delivery: Global Markets

Publisher Name :
Date: 25-Jun-2021
No. of pages: 109

Report Scope

This report aims to provide a comprehensive study of the global market for transdermal drug delivery technologies/systems. It provides a detailed description of the different types of transdermal drug delivery systems (passive and active) and the current and historical market revenues.

Transdermal drug delivery technologies/systems include passive transdermal drug delivery and active transdermal drug delivery. Passive transdermal drug delivery technologies/systems are segmented into matrix, reservoir and other transdermal drug delivery technologies/systems.

This report also offers a detailed study of therapeutic applications for transdermal drug delivery: pain, central nervous system (CNS) disorders, hormonal applications, smoking cessation, motion sickness, cardiovascular disorders and others. An in-depth analysis of the global market for transdermal drug delivery technologies/systems includes historical data and market projection of sales by technology/system type, therapeutic application, end-user and region.

For in-depth understanding of the market, profiles of market participants, key marketed products, competitive landscape, key competitors and respective market shares have been provided. This report also discusses driving and restraining factors of the global transdermal drug delivery technology/device market.

Report Includes

- 60 tables

- An overview of the global markets for transdermal drug delivery (TDD) technologies/systems within the pharmaceutical industry

- Analyses of the global market trends, with data from 2020, estimates for 2021, and projections of compound annual growth rates (CAGRs) through 2026

- Market outlook and forecast trends of clinical application areas and end user segments of transdermal drug delivery technologies/systems

- Estimation of market size and revenue forecast for TDD market, and corresponding market share analysis by technology/system type, therapeutic application, end-user, and region

- Discussion of the key market dynamics (DROs), industry structure, regulatory approval, market deterrents, unmet needs and other factors driving opportunities in pharmaceutical research

- Review of patents, new developments and emerging technologies, clinical trials for many pipeline products, and potential markets for future developments

- Impact analysis of the Covid-19 pandemic on transdermal drug delivery systems market as against the overall pharmaceuticals industry

- Insight into recent industry activities, competitive landscape of the major players operating within the global market, and their corresponding company share analysis

- Profile descriptions of the leading drug delivery companies including AbbVie, Dr. Reddy's Laboratories Ltd., Bayer, GlaxoSmithKline, Johnson & Johnson, Novartis AG, Teva Pharmaceutical, and Viatris

Summary

Transdermal drug delivery systems (TDDSs: gels, patches, films, etc.) are placed on the skin and allow specific drug substances to penetrate into the bloodstream through the layers of the skin. TDDSs have many benefits compared to other methods of drug delivery (oral, injectable, etc.) TDDSs mitigate the hepatic first pass effect of drugs, offering safety and a better quality of life to the patient. TDDSs are used to treat a wide variety of conditions and diseases, including pain, CNS disorders, hormone imbalance, prevention of nausea and vomiting, cardiovascular diseases (CVD), overactive bladder and several others. Most TDDSs are available in the form of patches.

Transdermal drug delivery (TDD) is still a relatively niche segment, currently accounting for a small market share in the overall drug delivery market. However, given the many advantages (ease of use, better patient compliance, improved bioavailability and fewer adverse effects, etc.) over other drug delivery options (oral and injections) TDD has gained increasing attention over the last decade. TDDSs hold huge potential to address the needs of an increasing global elder population, especially in caregiver-intensive conditions and for patients with chronic conditions. Opportunity exists to translate drug needs into a dosage form that is more end-user (patient) and caregiver friendly. Regarding the patent cliff, TDD could make pharmaceutical companies more competitive. For example, a pharmaceutical company that focuses on life cycle management and TDD as a parallel path during development could be in a better position to extend the life of a drug and to strategically introduce a variety of formulations that drive patient preference.

The global TDD market is estimated to have been worth nearly $REDACTED in 2020. Between 2021 and 2026, the market is predicted to grow at a CAGR of REDACTED%, leading to a market value of $REDACTED in 2026. The advent of innovative, new approaches and continuous technology development is the key factor driving growth in the market. The growing number of elder patients and the increasing demand for convenient drug delivery options with easy self-administration are also facilitating market growth.

TDD biologics (e.g., peptides, proteins, nucleic acids) and the use of new drug delivery devices such as microneedle systems for transdermal drug delivery, have high growth potential and are likely to have more activity in coming years. The opportunity areas in this market include TDD of large molecules underpinned by a large (multibillion) biologics market, wherein demand for advanced drug delivery systems is increasing.

Transdermal Drug Delivery: Global Markets

Table of Contents

Chapter 1 Introduction
Study Goals and Objectives
Scope of This Report
Methodology and Information Sources
Geographic Breakdown
Analyst's Credentials
BCC Custom Research
Related BCC Research Reports

Chapter 2 Summary and Highlights

Chapter 3 Market and Technology Background
Overview of Transdermal Drug Delivery Systems
Mechanism of Transdermal Drug Delivery
Advantages of Transdermal Drug Delivery
Disadvantages of Transdermal Drug Delivery
TDSS Types/Forms
Transdermal Patch
Transdermal Gel
Transdermal Spray
Transdermal Ointment
TDDS Technology Types
Passive TDDS
Types of Passive TDDS
Active TDDSs
Types of Active TDDS
Clinical Application of TDDS
Pain Management
CNS Disorders
Hormonal Applications
Smoking Cessation
Motion Sickness
Cardiovascular Diseases (CVD)
Others
End Users of TDDSs
Home Care Settings
Hospitals and Healthcare Clinics

Chapter 4 Market Breakdown by Technology Type
Global Market for TDDSs by Type
Passive TDDSs by Type
Passive TDDSs by Region
Active TDDSs by Region

Chapter 5 Market Breakdown by Application
Global Market for TDDS by Therapeutic Application
Market Size and Forecast by Therapeutic Application Type
Pain
CNS Disorders
Hormonal Applications
Smoking Cessation
Motion Sickness
CVD
Other Therapeutic Applications for TDDSs

Chapter 6 Market Breakdown by Region
Global Markets for TDDSs by Region
North America
Europe
Asia-Pacific
RoW

Chapter 7 Market Breakdown by End User
Global Markets for TDDS by End User
Market Size and Forecast by End User
North American End-User Market
European End-User Market
Asia-Pacific End-User Market
RoW

Chapter 8 New Developments and Emerging Technologies
Innovative Transdermal Technologies
Technologies by Hisamitsu Pharmaceutical Co. Inc.
Technologies by 4 P Therapeutics (Nutriband)
Technologies by Corium Inc.
Technologies by Tapemark
Emerging Technologies and Applications for TDDS
Company/System

Chapter 9 Market Dynamics
Market Trends and Growth Drivers
Aging Population
Technology Innovations and New Product Development
Increasing Awareness
Large Unpenetrated Addressable Market
Market Restraining Factors
Product Development and Manufacturing Challenges
The Barrier Nature of the Skin
Side Effects
High Cost of Drug Development and Pricing Pressure
Market opportunity
Repositioning of Currently Marketed Products

Chapter 10 Competitive Landscape
Overview
Key Available TDDSs
Pain Management
Hormone Replacement Therapy
Female Contraception
CNS Disorders
Smoking Cessation
Motion Sickness
For Cardiovascular Diseases
Overactive Bladder
Other Applications
Global Market Shares of Leading Companies
Recent Industry Activities
Product Launches and Approvals
Agreements and Collaborations
Acquisitions and Mergers
Others

Chapter 11 Impact of COVID-19 Pandemic

Chapter 12 Company Profiles
ABBVIE INC.
ACRUX LTD.
ALVOGEN
AMNEAL PHARMACEUTICALS INC.
BAYER HEALTHCARE PHARMACEUTICALS
BOEHRINGER INGELHEIM INTERNATIONAL GMBH
DR. REDDY'S LABORATORIES LTD.
ENDO PHARMACEUTICALS INC.
GLAXOSMITHKLINE PLC
HISAMITSU PHARMACEUTICAL CO. INC.
JOHNSON & JOHNSON
KYOWA KIRIN CO. LTD.
LAVIPHARM S. A.
LUYE PHARMA GROUP LTD.
NOVARTIS AG
NOVEN PHARMACEUTICALS INC.
PERRIGO COMPANY PLC
PURDUE PHARMA LP
TAPEMARK
TEVA PHARMACEUTICAL INDUSTRIES LTD.
UCB S.A.
USPHARMA LTD.
VERTICAL PHARMACEUTICALS LLC
VIATRIS INC.

Chapter 13 Appendix: Acronyms

List of Tables
Summary Table : Global Market for Transdermal Drug Delivery Systems, by Type, Through 2026
Table 1 : Difference Between Topical and Transdermal Drug Delivery Systems
Table 2 : Currently Marketed Transdermal Drugs
Table 3 : Classification of Transdermal Drugs for Pain Management
Table 4 : OTC and Prescription Classifications
Table 5 : Classification of Transdermal Drugs Used for CNS Disorders
Table 6 : Classification of Transdermal Drugs Used for Motion Sickness
Table 7 : Classification of Transdermal Drugs Used for CVD
Table 8 : Classification of Transdermal Drugs for Other Applications
Table 9 : Global Market for Transdermal Drug Delivery Systems, by Type, Through 2026
Table 10 : Global Market for Passive Transdermal Drug Delivery Systems, by Type, Through 2026
Table 11 : Global Market for Passive Transdermal Drug Delivery Systems, by Region, Through 2026
Table 12 : Global Market for Active Transdermal Drug Delivery Systems, by Region, Through 2026
Table 13 : Global Market for Transdermal Drug Delivery Systems, by Therapeutic Application, Through 2026
Table 14 : Global Market for Transdermal Drug Delivery Systems for Pain Management, by Region, Through 2026
Table 15 : Global Market for Transdermal Drug Delivery Systems Indicated for CNS Disorders, by Region, Through 2026
Table 16 : Global Market for Transdermal Drug Delivery Systems for Hormonal Applications, by Region, Through 2026
Table 17 : Global Market for Transdermal Drug Delivery Systems for Smoking Cessation, by Region, Through 2026
Table 18 : Global Market for Transdermal Drug Delivery Systems for Motion Sickness, by Region, Through 2026
Table 19 : Global Market for Transdermal Drug Delivery Systems for CVD, by Region, Through 2026
Table 20 : Global Market for Transdermal Drug Delivery Systems for Other Therapeutic Applications, by Region, Through 2026
Table 21 : Global Market for Transdermal Drug Delivery Systems, by Region, Through 2026
Table 22 : Elder Population, Selected European Countries
Table 23 : Global Market for Transdermal Drug Delivery Systems, by End User, Through 2026
Table 24 : North American Market for Transdermal Drug Delivery Systems, by End User, Through 2026
Table 25 : European Market for Transdermal Drug Delivery Systems, by End User, Through 2026
Table 26 : Asia-Pacific Market for Transdermal Drug Delivery Systems, by End User, Through 2026
Table 27 : RoW Market for Transdermal Drug Delivery Systems, by End User, Through 2026
Table 28 : Industry-Funded Clinical Trials for Transdermal Drug Delivery Systems, 2021
Table 29 : Total Elder Population, by Country, 2008 and 2018
Table 30 : Key Manufacturers, Transdermal Drug Delivery Systems for Pain Management
Table 31 : Key Manufacturers, Transdermal Drug Delivery Systems for Hormonal Replacement Therapy
Table 32 : Key Manufacturers, Transdermal Drug Delivery Systems for Female Contraception
Table 33 : Key Manufacturers of Transdermal Drug Delivery Systems for CNS Disorders
Table 34 : Key Manufacturers of Transdermal Drug Delivery Systems for Smoking Cessation
Table 35 : Key Manufacturers of Transdermal Drug Delivery Systems for Motion Sickness
Table 36 : Key Manufacturers of Transdermal Drug Delivery Systems for CVD
Table 37 : Key Manufacturers of Transdermal Drug Delivery Systems for Overactive Bladder
Table 38 : Key Manufacturers of Transdermal Drug Delivery Systems for Other Applications
Table 39 : Leading Company's Share in Transdermal Drug Delivery Systems, 2020
Table 40 : AbbVie Inc.: Transdermal Drug Delivery Product Portfolio
Table 41 : Alvogen: Transdermal Drug Delivery Product Portfolio
Table 42 : Amneal Pharmaceuticals Inc.: Transdermal Drug Delivery Product Portfolio
Table 43 : Bayer Healthcare Pharmaceuticals: Transdermal Drug Delivery Product Portfolio
Table 44 : Boehringer Ingelheim International GmbH: Transdermal Drug Delivery Product Portfolio
Table 45 : Endo Pharmaceuticals Inc.: Transdermal Drug Delivery Product Portfolio
Table 46 : GlaxoSmithKline PLC: Transdermal Drug Delivery Product Portfolio
Table 47 : Hisamitsu Pharmaceutical Co. Inc.: Rx Product Portfolio
Table 48 : Hisamitsu Pharmaceutical Co. Inc.:OTC Pain Relief Products
Table 49 : Johnson & Johnson: Transdermal Drug Delivery Product Portfolio
Table 50 : Kyowa Kirin Co. Ltd.: Transdermal Drug Delivery Product Portfolio
Table 51 : Lavipharm: Transdermal Drug Delivery Product Portfolio
Table 52 : Luye Pharma Group Ltd.: Transdermal Drug Delivery Product Portfolio
Table 53 : Novartis AG: Transdermal Drug Delivery Product Portfolio
Table 54 : Perrigo Company PLC.: Transdermal Drug Delivery Product Portfolio
Table 55 : Purdue Pharma LP: Transdermal Drug Delivery Product Portfolio
Table 56 : Teva Pharmaceutical Industries Ltd.: Transdermal Drug Delivery Product Portfolio
Table 57 : UCB S.A.: Transdermal Drug Delivery Product Portfolio
Table 58 : USpharma: Transdermal Drug Delivery Product Portfolio
Table 59 : Viatris Inc.: Transdermal Drug Delivery Product Portfolio
Table 60 : Acronyms Used in This Report

List of Figures
Summary Figure : Global Market for Transdermal Drug Delivery Systems, by Type, 2020-2026
Figure 1 : Mechanism of Transdermal Drug Delivery System
Figure 2 : Single Layer Drug in Adhesive Transdermal Delivery System
Figure 3 : Multi-Layer Drug in Adhesive Transdermal Delivery System
Figure 4 : Matrix Transdermal Delivery System
Figure 5 : Reservoir Transdermal Delivery System
Figure 6 : Global Market Shares of Transdermal Drug Delivery Systems, by Type, 2020
Figure 7 : Global Market for Passive Transdermal Drug Delivery Systems, by Type, 2020
Figure 8 : Global Market Shares of Passive Transdermal Drug Delivery Systems, by Region, 2020
Figure 9 : Global Market Shares of ActiveTransdermal Drug Delivery Systems, by Region, 2020
Figure 10 : Global Market Shares of Transdermal Drug Delivery Systems, by Therapeutic Application, 2020
Figure 11 : Global Market Shares of Transdermal Drug Delivery Systems for Pain Management, by Region, 2020
Figure 12 : Global Market for Transdermal Drug Delivery Systems Indicated for CNS Disorders, by Region, 2020
Figure 13 : Global Market Shares of Transdermal Drug Delivery Systems for Hormonal Applications, by Region, 2020
Figure 14 : Global Market Shares of Transdermal Drug Delivery Systems for Smoking Cessation, by Region, 2020
Figure 15 : Global Market Shares of Transdermal Drug Delivery Systems for Motion Sickness, by Region, 2020
Figure 16 : Global Market Shares of Transdermal Drug Delivery Systems for CVD, by Region, 2020
Figure 17 : Global Market Shares of Transdermal Drug Delivery Systems for Other Therapeutic Applications, by Region, 2020
Figure 18 : Global Market Shares of Transdermal Drug Delivery Systems, by Region, 2020
Figure 19 : Global Market Shares of Transdermal Drug Delivery Systems, by End User, 2020
Figure 20 : North American Market Shares of Transdermal Drug Delivery Systems, by End User, 2020
Figure 21 : European Market Shares of Transdermal Drug Delivery Systems, by End User, 2020
Figure 22 : Asia-Pacific Market Shares of Transdermal Drug Delivery Systems, by End User, 2020
Figure 23 : RoW Market Shares of Transdermal Drug Delivery Systems, by End User, 2020
  • Global Liposomes Drug Delivery Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026
    Published: 21-Sep-2021        Price: US 3480 Onwards        Pages: 109
    The Liposomes Drug Delivery market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations. According to our latest......
  • Global and China Nanotechnology Drug Delivery Market Size, Status and Forecast 2021-2027
    Published: 21-Sep-2021        Price: US 3900 Onwards        Pages: 98
    Global Nanotechnology Drug Delivery Scope and Market Size Nanotechnology Drug Delivery market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Nanotechnology Drug Delivery market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027. ......
  • United States Liposome Drug Delivery Market Report & Forecast 2021-2027
    Published: 20-Sep-2021        Price: US 3400 Onwards        Pages: 91
    United States Liposome Drug Delivery Market, By Type, 2016-2021, 2022-2027 ($ Millions) & (K Vial) United States Liposome Drug Delivery Market Segment Percentages, By Type, 2020 (%) - Liposomal Doxorubicin - Liposomal Amphoteracin B - Liposomal Paclitaxel - Others United States Liposome Drug Delivery Market, By Application, 2016-2021, 2022-2027 ($ Millions) & (K Vial) United States Liposome Drug Delivery Market Segment Percentages, By Appl......
  • United States Liposomes Drug Delivery Market Report & Forecast 2021-2027
    Published: 20-Sep-2021        Price: US 3400 Onwards        Pages: 94
    United States Liposomes Drug Delivery Market, By Type, 2016-2021, 2022-2027 ($ Millions) & (K Vials) United States Liposomes Drug Delivery Market Segment Percentages, By Type, 2020 (%) - Liposomal Doxorubicin - Liposomal Amphoteracin B - Liposomal Paclitaxel - Others United States Liposomes Drug Delivery Market, By Application, 2016-2021, 2022-2027 ($ Millions) & (K Vials) United States Liposomes Drug Delivery Market Segment Percentages, B......
  • Global and Japan Injectable Drug Delivery Formulation Market Insights, Forecast to 2027
    Published: 17-Sep-2021        Price: US 3900 Onwards        Pages: 132
    Injectable Drug Delivery Formulation market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Injectable Drug Delivery Formulation market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2016-2027. For Japan market, this repor......
  • Global and United States Transmucosal Drug Delivery Market Size, Status and Forecast 2021-2027
    Published: 17-Sep-2021        Price: US 3900 Onwards        Pages: 128
    Global Transmucosal Drug Delivery Scope and Market Size Transmucosal Drug Delivery market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Transmucosal Drug Delivery market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027. ......
  • United States Gold Nanoparticles Market Report & Forecast 2021-2027
    Published: 15-Sep-2021        Price: US 3400 Onwards        Pages: 108
    United States Gold Nanoparticles Market, By Type, 2016-2021, 2022-2027 ($ Millions) & (L) United States Gold Nanoparticles Market Segment Percentages, By Type, 2020 (%) - Water Soluble Gold Nanoparticles - Oil Soluble Gold Nanoparticles - Both Phase Soluble Gold Nanoparticles United States Gold Nanoparticles Market, By Application, 2016-2021, 2022-2027 ($ Millions) & (L) United States Gold Nanoparticles Market Segment Percentages, By Application,......
  • Global and Japan Liposome Drug Delivery Market Insights, Forecast to 2027
    Published: 13-Sep-2021        Price: US 3900 Onwards        Pages: 147
    Liposomes have been used to improve the therapeutic index of new or established drugs by modifying drug absorption, reducing metabolism, prolonging biological half-life or reducing toxicity. Drug distribution is then controlled primarily by properties of the carrier and no longer by physico-chemical characteristics of the drug substance only. In a liposome drug product, the drug substance is contained in liposomes. Typically, water soluble drugs are contained in the aqueous compartment(s) and hy......
  • 2021-2027 Global and Regional Gold Nanoparticles Industry Status and Prospects Professional Market Research Report Standard Version
    Published: 10-Sep-2021        Price: US 3500 Onwards        Pages: 145
    The global Gold Nanoparticles market was valued at 55.94 Million USD in 2020 and will grow with a CAGR of 12.6% from 2020 to 2027, based on HNY Research newly published report. The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in this field evaluate their business approaches. Also, this report covers market segmentation by major market verdors, types, applications/end users and geography(North America, East Asia, Europ......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs